<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The association of <z:mp ids='MP_0005048'>thrombosis</z:mp> and gestational morbidity with <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> is termed <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) </plain></SENT>
<SENT sid="1" pm="."><plain>Annexin 2 (A2) is a profibrinolytic endothelial cell surface receptor that binds plasminogen, its tissue activator (tPA), and beta(2)-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I (beta2GPI), the main antigen for <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we evaluate A2 as a target antigen in APS </plain></SENT>
<SENT sid="3" pm="."><plain>Serum samples from 434 individuals (206 patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> without <z:mp ids='MP_0005048'>thrombosis</z:mp>, 62 with APS, 21 with nonautoimmune <z:mp ids='MP_0005048'>thrombosis</z:mp>, and 145 healthy individuals) were analyzed by enzyme-linked immunosorbent assay (ELISA) and immunoblot for antiphospholipid and A2 antibodies </plain></SENT>
<SENT sid="4" pm="."><plain>Anti-A2 antibodies (titer &gt; 3 SDs) were significantly more prevalent in patients with APS (22.6%; venous, 17.5%; arterial, 34.3%; and mixed <z:mp ids='MP_0005048'>thrombosis</z:mp>, 40.4%) than in healthy individuals (2.1%, P &lt; .001), patients with nonautoimmune <z:mp ids='MP_0005048'>thrombosis</z:mp> (0%, P = .017), or patients with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> without <z:mp ids='MP_0005048'>thrombosis</z:mp> (6.3%, P &lt; .001) </plain></SENT>
<SENT sid="5" pm="."><plain>Anti-A2 IgG enhanced the expression of tissue factor on endothelial cells (6.4-fold +/- 0.13-fold SE), blocked A2-supported plasmin generation in a tPA-dependent generation assay (19%-71%) independently of beta2GPI, and inhibited cell surface plasmin generation on human umbilical vein endothelial cells (HUVECs) by 34% to 83% </plain></SENT>
<SENT sid="6" pm="."><plain>We propose that anti-A2 antibodies contribute to the prothrombotic diathesis in <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
</text></document>